Cibus, Inc. (CBUS)
NASDAQ: CBUS · Real-Time Price · USD
1.550
+0.080 (5.44%)
At close: Sep 29, 2026, 4:00 PM EDT
1.530
-0.020 (-1.29%)
After-hours: Sep 29, 2026, 7:30 PM EDT
Cibus Revenue
Cibus had revenue of $994.00K in the quarter ending June 30, 2026, with 6.54% growth. This brings the company's revenue in the last twelve months to $4.35M, down -10.30% year-over-year. In the year 2025, Cibus had annual revenue of $3.64M, down -14.62%.
Revenue (ttm)
$4.35M
Revenue Growth
-10.30%
P/S Ratio
27.25
Revenue / Employee
$36,839
Employees
118
Market Cap
118.46M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.64M | -623.00K | -14.62% |
| Dec 31, 2024 | 4.26M | 2.45M | 134.56% |
| Dec 31, 2023 | 1.82M | 1.66M | 1,057.32% |
| Dec 31, 2022 | 157.00K | -25.83M | -99.40% |
| Dec 31, 2021 | 25.99M | 2.14M | 8.96% |
| Dec 31, 2020 | 23.85M | 16.56M | 226.91% |
| Dec 31, 2019 | 7.30M | 7.06M | 2,991.53% |
| Dec 31, 2018 | 236.00K | -272.00K | -53.54% |
| Dec 31, 2017 | 508.00K | 109.00K | 27.32% |
| Dec 31, 2016 | 399.00K | -873.00K | -68.63% |
| Dec 31, 2015 | 1.27M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| LENZ Therapeutics | 21.48M |
| Coya Therapeutics | 8.02M |
| Milestone Pharmaceuticals | 2.34M |
| Inovio Pharmaceuticals | 65.34K |
| Genelux | 8.00K |
CBUS News
- 1 day ago - Cibus and Crystal Crop Protection Team Up to Improve India's Mustard Crop - GlobeNewsWire
- 6 weeks ago - Cibus Earnings Call Transcript: Q2 2026 - Transcripts
- 6 weeks ago - Cibus Earnings release: Q2 2026 - Filings
- 6 weeks ago - Cibus Quarterly report: Q2 2026 - Filings
- 6 weeks ago - Cibus Reports Second Quarter Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Cibus to Report Second Quarter 2026 Financial Results on August 13, 2026 After the Market Close and Host Conference Call - GlobeNewsWire
- 3 months ago - Cibus Transcript: Sidoti Small-Cap Virtual Investor Conference - Transcripts
- 3 months ago - Europe Recognizes Nature-Based Plant Improvement, Opening a New Pathway for Cibus - GlobeNewsWire